• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, August 9, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Endocrine Society objects to Title X gag rule that limits women’s access to contraception

Bioengineer by Bioengineer
February 22, 2019
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Denying preventive services increases medical costs, jeopardizes public health

WASHINGTON–The Endocrine Society objects to the administration’s decision to severely restrict access to the Title X Family Planning Program, the nation’s only program for affordable birth control and reproductive care.

The Title X program is essential in helping ensure that every person — regardless of income, identity, or whether or not they have health insurance — can access basic, preventive reproductive health care, such as birth control, cancer screenings, STI testing and treatment, and well-woman exams. Nearly 500,000 people submitted comments to the administration opposing the dismantling of the Title X program, and it has been denounced by every major medical association.

The Society advocates for continued access to preventive health care, including no-cost hormonal contraception, as outlined in its position statement. No-cost hormonal contraceptive services allow a woman to effectively plan, if, and when, she becomes pregnant. This has a positive impact on families’ socioeconomic status and health. The resulting reduction in unplanned pregnancies also has a positive impact on healthcare costs.

The changes to the Title X funding program will threaten women and adolescents’ ability to access medically-necessary preventive and reproductive health care in their communities. Federally qualified health centers will also become overwhelmed as the community-based health care centers that have been providing these services are eliminated from Title X eligibility.

By limiting women’s access to preventative care, the changes to the Title X funding program finalized by the administration will increase medical costs and cause many women with various disorders to forgo treatment. We urge the administration to eliminate these new eligibility criteria to ensure that all centers qualified to provide these services have equal opportunity to receive Title X grant funding.

###

Endocrinologists are at the core of solving the most pressing health problems of our time, from diabetes and obesity to infertility, bone health, and hormone-related cancers. The Endocrine Society is the world’s oldest and largest organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.

The Society has more than 18,000 members, including scientists, physicians, educators, nurses and students in 122 countries. To learn more about the Society and the field of endocrinology, visit our site at http://www.endocrine.org. Follow us on Twitter at @TheEndoSociety and @EndoMedia.

Media Contact
Colleen Williams
[email protected]
202-971-3611

Tags: EndocrinologyPolicy/Ethics
Share12Tweet8Share2ShareShareShare2

Related Posts

Calreticulin-targeted L-asparaginase–flagellin conjugate boosts Salmonella’s antitumor effectiveness

Calreticulin-targeted L-asparaginase–flagellin conjugate boosts Salmonella’s antitumor effectiveness

August 9, 2026

Short-Term Animal-Product Restriction Rapidly Alters Human Proteogenomic Profiles

August 9, 2026

UVA-Induced Hyperploidization Causes Fibrosis in Post-Mitotic Fuchs Dystrophy Corneal Cells

August 9, 2026

Healthy Vaccinee Effect Shapes Evaluation of Updated COVID-19 Vaccines in Older Adults

August 8, 2026
Please login to join discussion

POPULAR NEWS

  • Cigar, Cigarillo, and Pipe Smoking: Lung Cancer Risk and Screening Eligibility

    29 shares
    Share 12 Tweet 7
  • How Low Gravity and Pressure Affect Space Manufacturing of Carbon-Fiber Structures

    29 shares
    Share 12 Tweet 7
  • Calreticulin-targeted L-asparaginase–flagellin conjugate boosts Salmonella’s antitumor effectiveness

    29 shares
    Share 12 Tweet 7
  • Porous Reaction-Bonded Silicon Nitride: Size Effects in Pressureless Nitriding of Binder-Jetted Silicon

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Cigar, Cigarillo, and Pipe Smoking: Lung Cancer Risk and Screening Eligibility

How Low Gravity and Pressure Affect Space Manufacturing of Carbon-Fiber Structures

Calreticulin-targeted L-asparaginase–flagellin conjugate boosts Salmonella’s antitumor effectiveness

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 86 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.